0391 Methotrexate monotherapy has comparable long-term outcomes to methotrexate plus corticosteroids in the treatment of morphea
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S68
DOI: 10.1016/j.jid.2026.06.422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von V.K. Shah und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shah, V., Lateef, A., Rosas, E. D., Su, A., Havrilla, H., Torok, K., & Jacobe, H. (2026). 0391 Methotrexate monotherapy has comparable long-term outcomes to methotrexate plus corticosteroids in the treatment of morphea. Journal of Investigative Dermatology, 146(8), S68. https://doi.org/10.1016/j.jid.2026.06.422
Vancouver
Shah V, Lateef A, Rosas ED, Su A, Havrilla H, Torok K, et al. 0391 Methotrexate monotherapy has comparable long-term outcomes to methotrexate plus corticosteroids in the treatment of morphea. Journal of Investigative Dermatology. 2026;146(8):S68. doi:10.1016/j.jid.2026.06.422
BibTeX
@article{Shah2026,
author = {Shah, V.K. and Lateef, A. and Rosas, E. de and Su, A. and Havrilla, H. and Torok, K. and Jacobe, H.},
title = {0391 Methotrexate monotherapy has comparable long-term outcomes to methotrexate plus corticosteroids in the treatment of morphea},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S68},
doi = {10.1016/j.jid.2026.06.422}
}
EUVIMED